Evaluate Weigh the pros and cons of technologies, products and projects you are considering.

Should pharmaceutical companies invest in MDM services and software?

Find out if pharmaceutical companies should invest in MDM services and MDM software and how health science companies should manage their MDM programs.

What do you estimate that large and mid-tier pharmaceutical companies will spend on master data management (MDM) services and software from 2010 to 2012?

The money that pharma companies stand to save as a result of MDM will more than exceed their investments as long as they:

1. Deliberately plan their MDM programs. Successful MDM programs in pharma and health sciences mandate a requirements-driven, roadmap-enabled approach. This will also help with budgeting and resourcing -- ongoing challenges in many of these companies.

2. Apply rigor around their MDM investments. Pharma companies have a tendency to prefer vendors that are already in-house. We find that often translates into overinvestment.

Dig Deeper on MDM best practices

Have a question for an expert?

Please add a title for your question

Get answers from a TechTarget expert on whatever's puzzling you.

You will be able to add details on the next page.

Start the conversation

Send me notifications when other members comment.

Please create a username to comment.